SCHEMBL6545896

SCHEMBL6545896

COC(Sc1ccccc1)[Si](C)(C)C.[LiH]

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.33
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HPGD P15428 1/20 0.32
MGLL Q99685 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
MAPK1 P28482 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
PKM P14618 1/20 0.30
EPHX1 P07099 1/20 0.30
CA4 P22748 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8836724 0.98 L3MBTL1 (0.38) TDP1L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL8428763 0.70 MAOA (0.39) TDP1L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL27911540 0.70 LMNA (0.40) L3MBTL1LMNAMAPTSMN1; SMN2HPGD
SCHEMBL9210090 0.68 L3MBTL1 (0.40) TDP1L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL21253055 0.65 LMNA (0.44) TDP1L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL6542228 0.64 TDP1 (0.37) TDP1L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL6987805 0.64 KMT2A (0.37) TDP1L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL7219363 0.64 LMNA (0.33) TDP1L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL343269 0.63 SMN1; SMN2 (0.45) TDP1L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL1453001 0.63 SMN1; SMN2 (0.45) TDP1L3MBTL1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1420011-A1 Compounds usefulfor treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 2004-05-19 EP disclosed
EP-1380571-A1 Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 2004-01-14 EP disclosed
EP-0919544-B1 Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORP (US) 2003-05-14 EP disclosed
EP-0633776-B1 COMPOUNDS USEFUL FOR TREATING ALLERGIC AND INFLAMMATORY DISEASES SMITHKLINE BEECHAM CORP (US) 2001-05-09 EP disclosed
EP-0919544-A1 Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 1999-06-02 EP disclosed
US-5643946-A Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 1997-07-01 US disclosed
US-5614540-A Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 1997-03-25 US disclosed
US-5602157-A Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 1997-02-11 US disclosed
US-5552438-A Compounds useful for treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION (US) 1996-09-03 US disclosed
EP-0633776-A4 1995-01-25 EP disclosed
EP-0633776-A1 COMPOUNDS USEFUL FOR TREATING ALLERGIC AND INFLAMMATORY DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1995-01-18 EP disclosed
WO-1993019749-A1 COMPOUNDS USEFUL FOR TREATING ALLERGIC AND INFLAMMATORY DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1993-10-14 WO disclosed